

Lauro Cinquantasette S.p.A.: Private Company Information - Bloomberg








































  





















































































July 25, 2017 5:07 PM ET

Company Overview of Lauro Cinquantasette S.p.A.



Snapshot People




Company Overview



Milan, MI Italy










Key Executives for Lauro Cinquantasette S.p.A.


Lauro Cinquantasette S.p.A. does not have any Key Executives recorded. 





Similar Private Companies By Industry



Company Name
Region



 " C.A.F. S.N.C. - Centro Assistenza Fiscale - Di Paolucci Pieran- Gelo & Pasqualone Paola " Europe " Colorwash S.R.L. " Europe " Costruzioni Aeronautiche Tecnam S.R.L. " Europe " F.V.R. Di Dangeli Francesco E Fratelli-Societa' In Nome Collet- Tivo " Europe " Filma Plastica S.R.L. " Europe




Recent Private Companies Transactions



TypeDate
Target



No transactions available in the past 12 months.




Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Lauro Cinquantasette S.p.A., please visit --.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





































 












































Lauro Cinquantasette S.p.A.: CEO and Executives - Bloomberg







































  





















































































July 25, 2017 5:07 PM ET

Company Overview of Lauro Cinquantasette S.p.A.



SnapshotPeople 




OverviewBoard MembersCommittees



Key Executives for Lauro Cinquantasette S.p.A.
NameBoard RelationshipsTitleAgeThere is no Key Executives data available.
Lauro Cinquantasette S.p.A. Board Members*
NameBoard RelationshipsPrimary CompanyAgeThere is no Board Members data available.
Lauro Cinquantasette S.p.A. Executive Committees*
Committee NameChairpersonBoard RelationshipsMembersThere is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



CEO COMPENSATION IN THIS INDUSTRY  Industry Range










INDUSTRY EXECUTIVE CHANGESThere is no Executive Change data available.Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Lauro Cinquantasette S.p.A., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























Cinquantasette S.p.A.  Lauro - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Cinquantasette S.p.A.  Lauro
Check out list of companies and businesses related to Cinquantasette S.p.A.  Lauro. Find out Cinquantasette S.p.A.  Lauro address and contact details. View other people related to Cinquantasette S.p.A.  Lauro - coworkers, colleagues, companions, etc.
Address:   

VIA DEL LAURO, 7  MILANO 20121 Italy




Companies related to Cinquantasette S.p.A.  Lauro
CIKCompany NamePositionCompany Address0001065087ALBANY MOLECULAR RESEARCH INC21 CORPORATE CIRCLE P O BOX 15098 ALBANY 12203-5154




Cinquantasette S.p.A.  Lauro on the Web
Persons related to Cinquantasette S.p.A.  Lauro - ALBANY MOLECULAR RESEARCH INCNamePositionCityPAUL S  ANDERSONDirector ALBANYAVENTIS INCBRIDGEWATERMILTON  BOYERSVP, Drug Product Manufacturin ALBANYSTUART M  CABLE10% Owner COLUMBIASTUART M  CABLE10% Owner BOSTONSTUART M  CABLE10% Owner BOSTONSTUART M  CABLE10% Owner BOSTONS.G.R. S.p.A.  ClessidraMILANOCHRISTOPHER M.  CONWAYSVP, Discovery and Development ALBANYAMBRA CONSTANCE M  D10% Owner ALBANYAMBRA CONSTANCE M  D10% Owner ALBANYDavid  D'AmbraALBANYAMBRA THOMAS E PHD  DDirector ALBANYAMBRA THOMAS E PHD  DChairman, Board of Directors ALBANYGeoffrey  DAmbraALBANYDavid H  DemingDirector SAN DIEGOJohnathan D  EvansVP Pharma Dev & Manu ALBANYMARGALIT  FINEExecutive Vice President, API ALBANYMark T  FrostChief Financial Officer ALBANYJAMES J  GRATESVP, Operations ALBANYFuentes Luis Gerardo  GutierrezDirector ALBANYKENNETH PAUL  HAGENDirector ALBANYSteven R  HagenSVP Manufacturing & Pharmaceut ALBANYSteven R  HagenSr VP Pharmaceutical Dev & Mfg ALBANYSteven R  HagenSVP Pharmaceutical Dev & Mfg ALBANYFRANK  HAYDUDirector ALBANYLORI M  HENDERSONSVP, Secretary & Gen Counsel WAYLANDLORI M  HENDERSONVP, general counsel ALBANYLORI M  HENDERSONVP, Secretary & Gen. Counsel ALBANYLORI M  HENDERSONSVP, Secretary & Gen. Counsel ALBANYWILLIAM STEVEN  JENNINGSSenior Vice President ALBANYLAWRENCE D  JONESSr. VP, Business Development ALBANYVeronica GH  JordanDirector ALBANYDONALD E  KUHLADirector ALBANYFelicia I  LadinSVP, Treasurer & CFO ALBANYCinquantasette S.p.A.  LauroMILANOQuarantotto S.p.A.  LauroMILANOGABRIEL  LEUNGDirector MELVILLEGABRIEL  LEUNGDirector ALBANYGABRIEL  LEUNGDirector ALBANYMichael A  LutherSenior VP, Discovery Services ALBANYMichael A  LutherSenior VP, Discovery Services ALBANYANTHONY J  MADDALUNADirector NEW YORKCapital Management Secondary SA  MandarinLUXEMBOURGCapital Partners Secondary SCA SICAR  MandarinLUXEMBOURGWilliam S  MarthPresident and CEO ALBANYWilliam S  MarthPresident and CEO ALBANYWilliam S  MarthPresident and CEO ALBANYFERNANDO  NAPOLITANODirector ALBANYMichael M  NolanCFO ALBANYMichael M  NolanVP, CFO and Treasurer ALBANYMichael M  NolanSVP, CFO and Treasurer ALBANYKEVIN  OCONNORDirector ALBANYARTHUR J  ROTHDirector ALBANYARTHUR J  ROTHDirector ALBANYUNA S  RYANDirector CHESTNUT HILLUNA S  RYANDirector ALBANYBruce J  SargentSr VP, Drug Discovery ALBANYKenton L  ShultisVP and GM, Organichem ALBANYGeorge  SvokosChief Operating Officer ALBANYGeorge  SvokosSr. VP Sales & GM of API ALBANYGeorge  SvokosSVP Sales & GM of API ALBANYANTHONY P  TARTAGLIADirector ALBANYTHOMAS DAMBRA SLAT TRUSTALBANYMICHAEL P  TROVASr. VP, Chemistry ALBANYDAVID P  WALDEKChief Financial Officer ALBANY












 














Lauro Cinquantasette S.p.A. - PBV Monitor



































 Home
Client dossier
Lauro Cinquantasette S.p.A.








Lauro Cinquantasette S.p.A.
World-Wide Activities






2 
analized transaction
700 Eur. ML
aggregated deals value




Last 12 months dossier





2 
analized transaction
700 Eur. ML
aggregated deals value




Full dossier 











Legal Advisors








Search




Lauro Cinquantasette S.p.A. World-wide Activity

A world map will load here!




ITALY
UNITED STATES


Select




Select Practice Area

Corporate - M&A


Select












News



8/25/2016 ENAlbany Molecular Research, Inc. acquires  Prime European Therapeuticals S.p.A. from Lauro Cinquantasette S.p.A.Goodwin Procter and LCA Studio Legale represented AMRI.

Chiomenti Studio Legale and Debevoise & Plimpton has advised Lauro 57.Details8/25/2016 ENAlbany Molecular Research, Inc. acquires  Prime European Therapeuticals S.p.A. from Lauro Cinquantasette S.p.A.Goodwin Procter and LCA Studio Legale represented AMRI.
Chiomenti Studio Legale and Debevoise & Plimpton has advised Lauro 57.
Details













Practice Area



FusionCharts XT will load here!





 
Active Lawyers
Law Firms



Active Lawyers
The Chart shows a balanced list of partners advising Lauro Cinquantasette S.p.A. - based on PBV Monitor's analyzed transactions 





Maurizio Levi-Minzi / Debevoise & Plimpton - Peter Furci / Debevoise & Plimpton - 
		







Law Firms
The Chart shows a balanced list of Lauro Cinquantasette S.p.A....... - based on PBV Monitor's analyzed transactions





Debevoise & Plimpton














Results are based upon public information and may undervalue a law firm's and/or a lawyer's professional experience and client portfolio.
































LAURO CINQUANTASETTE S.P.A. SC 13D/A Filing Concerning AMRI on 2016-09-28  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active


















Schedule  13D/A















Filed by:


					LAURO CINQUANTASETTE S.P.A.
				


Total Shares:

                          7,051,295
			


Subject Company:


					Albany Molecular Research Inc
                  -
                  View Complete Ownership History

          Backtest
        



Filed as of Date:
10/12/2016


Event Date:
09/28/2016


Overall % Ownership:
16.49


Reporting Persons



Name
SoleVoting Power
SharedVoting Power
SoleDispositive Power
SharedDispositive Power
AggregateAmount Owned
Percentof class


Lauro Cinquantasette SpA
0
7,051,295
0
7,051,295
7,051,295
16.49%


Lauro Quarantotto SpA
0
7,051,295
0
7,051,295
7,051,295
6.82%


Clessidra SGR SpA
0
7,051,295
0
7,051,295
7,051,295
6.82%


Mandarin Capital Partners Secondary SCA SICAR
0
7,051,295
0
7,051,295
7,051,295
4.05%


Mandarin Capital Management Secondary SA
0
7,051,295
0
7,051,295
7,051,295
0.405%





					View Original Filing on Edgar's
				


Raw Filing Contents
0001144204-16-127841.txt : 20161012
0001144204-16-127841.hdr.sgml : 20161012
20161012160202
ACCESSION NUMBER:		0001144204-16-127841
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20161012
DATE AS OF CHANGE:		20161012
GROUP MEMBERS:		CLESSIDRA S.G.R. S.P.A.
GROUP MEMBERS:		LAURO QUARANTOTTO S.P.A.
GROUP MEMBERS:		MANDARIN CAPITAL MANAGEMENT SECONDARY S.A.
GROUP MEMBERS:		MANDARIN CAPITAL PARTNERS SECONDARY S.C.A. SICAR

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALBANY MOLECULAR RESEARCH INC
		CENTRAL INDEX KEY:			0001065087
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				141742717
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-57327
		FILM NUMBER:		161933246

	BUSINESS ADDRESS:	
		STREET 1:		21 CORPORATE CIRCLE
		STREET 2:		P O BOX 15098
		CITY:			ALBANY
		STATE:			NY
		ZIP:			12203-5154
		BUSINESS PHONE:		5184640279

	MAIL ADDRESS:	
		STREET 1:		21 CORPORATE CIRCLE
		STREET 2:		P O BOX 15098
		CITY:			ALBANY
		STATE:			NY
		ZIP:			12203-5154

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lauro Cinquantasette S.p.A.
		CENTRAL INDEX KEY:			0001679208
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		VIA DEL LAURO, 7
		CITY:			MILANO
		STATE:			L6
		ZIP:			20121
		BUSINESS PHONE:		39-02-8695221

	MAIL ADDRESS:	
		STREET 1:		VIA DEL LAURO, 7
		CITY:			MILANO
		STATE:			L6
		ZIP:			20121


SC 13D/A
1
v450243_sc13d-a.htm
SC 13D/A




 
  
UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
 
 

 
SCHEDULE 13D
 
Under the Securities
Exchange Act of 1934
Amendment No. 2
 

 

 

Albany
Molecular Research, Inc.
(Name of Issuer)

Common Stock, par value $0.01
(Title of Class of Securities)
 
012423109
(CUSIP Number)
 
Lauro Cinquantasette
S.p.A.
Via del Lauro, 7
20121 Milano, Italy
Attention: Enrico Ricotta
+39-02-8695221
 
Lauro Quarantotto S.p.A.
Via del Lauro, 7
20121 Milano, Italy
Attention: Marco Carotenuto
+39-02-8695221
 
Clessidra S.G.R. S.p.A.
Via del Lauro, 7
20121 Milano, Italy
Attention: Riccardo
Bruno
+39-02-8695221
 
Mandarin Capital Partners
Secondary S.C.A. SICAR
10, Rue Antoine Jans
L-1820 Luxembourg
Attention: Massimo
Longoni & Lorenzo Stanca
+352-27-85-80-50-1
 
Mandarin Capital Management
Secondary S.A.
10, Rue Antoine Jans
L-1820 Luxembourg
Attention: Massimo
Longoni & Lorenzo Stanca
+326-26-73-85-1
 
With copies to:
Debevoise & Plimpton
LLP
919 Third Avenue
New York, NY 10022
Attention: Maurizio
Levi-Minzi, Esq.
(212) 909-6306
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
September 28, 2016
(Date of Event which Requires
Filing of this Statement)
 
If the filing person has previously filed
a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because
of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box £.
 

 

Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule
13d-7 for other parties to whom copies are to be sent.

 

 

*The remainder of this cover page shall be filled out
for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page.

 
The information required on the remainder
of this cover page shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section of the Exchange Act
but shall be subject to all other provisions of the Exchange Act (however, see the Notes).
 
(Continued on following
pages)
 
 

 
 


 



CUSIP No. 012423109    
13D
 


 




 
1

 
NAME OF REPORTING PERSON
 
Lauro Cinquantasette S.p.A.


 
2

 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
 
(a) ☑	(b)
        ¨ *


 
3

 
SEC USE ONLY


 
4

 
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
OO


 
5

 
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
        TO ITEMS 2(d) OR (2e)
 
¨


 
6

 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Italy


 
 
NUMBER OF 
SHARES BENEFICIALLY OWNED BY 
EACH 
REPORTING
PERSON
WITH

 
7

 
SOLE VOTING POWER
 
0


 
8

 
SHARED VOTING POWER
 
7,051,295


 
9

 
SOLE DISPOSITIVE POWER
 
0


 
10

 
SHARED DISPOSITIVE POWER
 
7,051,295


 
11

 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
16.49% **


 
12

 
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
        (SEE INSTRUCTIONS)
 
Item ☑
*


 
13

 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
16.49%


 
14
 

 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
OO 


 
 


  

*To the extent that the parties to the Stockholders Agreement
(as defined in Item 6 of the Statement (as defined below)), the Lauro 57 Shareholders Agreement (as defined in Item 5(b) of the
Statement) or the Amended Lauro 57 Shareholders Agreement (as defined below in Item 5(b) of the Statement) may be deemed to constitute
a “group” within the meaning of Section 13(d) of the Exchange Act, and the Reporting Persons may be deemed to share
beneficial ownership of the shares of Common Stock owned by the other stockholder parties to the Stockholders Agreement or the
other shareholder parties to the Lauro 57 Shareholders Agreement or the Amended Lauro 57 Shareholders Agreement, as applicable,
the Reporting Persons expressly disclaim beneficial ownership of any shares of Common Stock held by such other parties.

 

**See Item 5 of the Statement and this Amendment No. 2
(as defined below) for discussion of calculation of beneficial ownership and percentage of ownership.

 


 2 
 

   



CUSIP No. 012423109    
13D
 


 




 
1

 
NAME OF REPORTING PERSON
 
Lauro Quarantotto S.p.A.


 
2

 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
 
(a)
☑            (b) ¨ *


 
3

 
SEC USE ONLY
 


 
4

 
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
OO


 
5

 
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
        TO ITEMS 2(d) OR (2e)
 
¨


 
6

 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Italy


 
 
NUMBER OF 
SHARES 
BENEFICIALLY 
OWNED BY 
EACH 
REPORTING
PERSON
WITH

 
7

 
SOLE VOTING POWER
 
0


 
8

 
SHARED VOTING POWER
 
7,051,295


 
9

 
SOLE DISPOSITIVE POWER
 
0


 
10

 
SHARED DISPOSITIVE POWER
 
7,051,295


 
11

 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
6.82% **


 
12

 
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
        (SEE INSTRUCTIONS)
 
Item ☑ *


 
13

 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
6.82%


 
14
 

 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
OO


 

*To the extent that the parties to the Stockholders Agreement,
the Lauro 57 Shareholders Agreement or the Amended Lauro 57 Shareholders Agreement may be deemed to constitute a “group”
within the meaning of Section 13(d) of the Exchange Act, and the Reporting Persons may be deemed to share beneficial ownership
of the shares of Common Stock owned by the other stockholder parties to the Stockholders Agreement or the other shareholder parties
to the Lauro 57 Shareholders Agreement or the Amended Lauro 57 Shareholders Agreement, as applicable, the Reporting Persons expressly
disclaim beneficial ownership of any shares of Common Stock held by such other parties.

 

**See Item 5 of the Statement and this Amendment No. 2 for discussion of calculation of beneficial ownership and percentage of
ownership.
 
 

 3 
 


 



CUSIP No. 012423109    
13D
 


 




 
1

 
NAME OF REPORTING PERSON
 
Clessidra S.G.R. S.p.A.


 
2

 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
 
(a) ☑    (b)
¨ *



 
3

 
SEC USE ONLY
 


 
4

 
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
OO


 
5

 
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
        TO ITEMS 2(d) OR (2e)
 
¨


 
6

 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Italy


 
 
NUMBER OF 
SHARES 
BENEFICIALLY 
OWNED BY 
EACH 
REPORTING
PERSON
WITH

 
7

 
SOLE VOTING POWER
 
0


 
8

 
SHARED VOTING POWER
 
7,051,295


 
9

 
SOLE DISPOSITIVE POWER
 
0


 
10

 
SHARED DISPOSITIVE POWER
 
7,051,295


 
11

 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
6.82% **


 
12

 
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
        (SEE INSTRUCTIONS)
Item ☑ *


 
13

 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
6.82%


 
14
 

 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
OO


 

*To the extent that the parties to the Stockholders Agreement,
the Lauro 57 Shareholders Agreement or the Amended Lauro 57 Shareholders Agreement may be deemed to constitute a “group”
within the meaning of Section 13(d) of the Exchange Act, and the Reporting Persons may be deemed to share beneficial ownership
of the shares of Common Stock owned by the other stockholder parties to the Stockholders Agreement or the other shareholder parties
to the Lauro 57 Shareholders Agreement or the Amended Lauro 57 Shareholders Agreement, as applicable, the Reporting Persons expressly
disclaim beneficial ownership of any shares of Common Stock held by such other parties.

 

**See Item 5 of the Statement and this Amendment No. 2
for discussion of calculation of beneficial ownership and percentage of ownership.

 

 4 
 

  



CUSIP No. 012423109    
13D
 


  




 
1

 
NAME OF REPORTING PERSON
 
Mandarin Capital Partners Secondary S.C.A. SICAR


 
2

 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
 
(a)
        ☑	     (b) ¨ *


 
3

 
SEC USE ONLY
 


 
4

 
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
OO


 
5

 
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
        TO ITEMS 2(d) OR (2e)
 
¨


 
6

 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Luxembourg


 
 
NUMBER OF 
SHARES 
BENEFICIALLY 
OWNED BY 
EACH 
REPORTING
PERSON
WITH

 
7

 
SOLE VOTING POWER
 
0


 
8

 
SHARED VOTING POWER
 
7,051,295


 
9

 
SOLE DISPOSITIVE POWER
 
0


 
10

 
SHARED DISPOSITIVE POWER
 
7,051,295


 
11

 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
4.05% **


 
12

 
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
        (SEE INSTRUCTIONS)
 
Item ☑ *


 
13

 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
4.05%


 
14
 

 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
OO 

 


*To the extent that the parties to the Stockholders Agreement,
the Lauro 57 Shareholders Agreement or the Amended Lauro 57 Shareholders Agreement may be deemed to constitute a “group”
within the meaning of Section 13(d) of the Exchange Act, and the Reporting Persons may be deemed to share beneficial ownership
of the shares of Common Stock owned by the other stockholder parties to the Stockholders Agreement or the other shareholder parties
to the Lauro 57 Shareholders Agreement or the Amended Lauro 57 Shareholders Agreement, as applicable, the Reporting Persons expressly
disclaim beneficial ownership of any shares of Common Stock held by such other parties.

 

**See Item 5 of the Statement and this Amendment No. 2
for discussion of calculation of beneficial ownership and percentage of ownership.

 

 5 
 

 



CUSIP No. 012423109    
13D
 


 




 
1

 
NAME OF REPORTING PERSON
 
Mandarin Capital Management Secondary S.A.


 
2

 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
 
(a)
        ☑      (b) ¨ *


 
3

 
SEC USE ONLY
 


 
4

 
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
OO


 
5

 
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
        TO ITEMS 2(d) OR (2e)
 
¨


 
6

 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Luxembourg


 
 
NUMBER OF 
SHARES 
BENEFICIALLY 
OWNED BY 
EACH 
REPORTING
PERSON
WITH

 
7

 
SOLE VOTING POWER
 
0


 
8

 
SHARED VOTING POWER
 
7,051,295


 
9

 
SOLE DISPOSITIVE POWER
 
0


 
10

 
SHARED DISPOSITIVE POWER
 
7,051,295


 
11

 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
0.405% **


 
12

 
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
        (SEE INSTRUCTIONS)
 
Item ☑ *


 
13

 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
0.405%


 
14
 

 
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
OO 


 

*To the extent that the parties to the Stockholders Agreement,
the Lauro 57 Shareholders Agreement or the Amended Lauro 57 Shareholders Agreement may be deemed to constitute a “group”
within the meaning of Section 13(d) of the Exchange Act, and the Reporting Persons may be deemed to share beneficial ownership
of the shares of Common Stock owned by the other stockholder parties to the Stockholders Agreement or the other shareholder parties
to the Lauro 57 Shareholders Agreement or the Amended Lauro 57 Shareholders Agreement, as applicable, the Reporting Persons expressly
disclaim beneficial ownership of any shares of Common Stock held by such other parties.

 

**See Item 5 of the Statement and this Amendment No. 2
for discussion of calculation of beneficial ownership and percentage of ownership.

 

 6 
 

 
This Amendment No. 2 amends and supplements
the statement on Schedule 13D initially filed by the Reporting Persons on July 18, 2016, as amended by Amendment No. 1 filed on
August 8, 2016 (as amended, the “Statement”). Information reported in the Statement remains in effect except
to the extent that it is amended, restated or superseded by information contained in this Amendment No. 2. Capitalized terms used
and not defined in this Amendment No. 2 shall have the meanings set forth in the Statement.
 
Item 2. Identity and
Background.
 
1. Item 2(a) of the Statement is hereby
amended and replaced in its entirety as follows:
 
“(a)	This statement
is being filed by the following persons:
 

(i)Lauro Cinquantasette S.p.A., a company organized under the laws of Italy (“Lauro 57”);
 

(ii)Lauro Quarantotto S.p.A., a company organized under the laws of Italy (“Lauro 48”);
 

(iii)Clessidra S.G.R. S.p.A., a company organized under the laws of Italy (“Clessidra”);
 

(iv)Mandarin Capital Partners Secondary S.C.A. SICAR, a company organized under the laws of Luxembourg (“MCPS”);
and
 

(v)Mandarin Capital Management Secondary S.A., a company organized under the laws of Luxembourg (“MCMS”, and
together with Lauro 57, Lauro 48, Clessidra and MCPS, the “Reporting Persons”, and each, a “Reporting
Person”).”
  
2. Item 2(b) of the Statement is hereby
amended and replaced in its entirety as follows:
 
“The address of the principal executive
offices of Lauro 57, Lauro 48 and Clessidra is Via del Lauro, 7, 20121 Milano, Italy. The address of the principal executive offices
of MCPS and MCMS is 10, Rue Antoine Jans, L-1820 Luxembourg.”
  
3. The first paragraph of Item 2(c) of the
Statement is hereby amended and replaced in its entirety as follows:
 
“Lauro 57, Lauro 48 and Clessidra’s
principal business addresses are in Italy. Lauro 57 and its subsidiaries operate in Italy, France, Germany and the United States
of America in the active pharmaceutical ingredients sector and in the customs synthesis and fine chemicals segments. Lauro 48 is
an investment entity controlled by Clessidra on behalf of the private equity fund Clessidra Capital Partners II (“CCPII”).
Clessidra is an asset management company authorized by the Bank of Italy that manages private equity funds, including CCPII, that
invest in medium to large sized companies in different industries. On September 14, 2016, Italmobiliare S.p.A. acquired 99% of
the share capital of Clessidra. MCPS’s and MCMS’s principal business addresses are in Luxembourg. MCPS is a private
equity fund. MCMS is the general partner of MCPS and makes all investment decisions on behalf of MCPS.”
 
 

 7 
 


 
4. Item 2(f) of the Statement is hereby
amended and replaced in its entirety as follows:
 
“Lauro 57, Lauro 48 and Clessidra are
each organized under the laws of Italy. MCPS and MCMS are each organized under the laws of Luxembourg.”
  
5. Annex A of the Statement is hereby amended
and replaced in its entirety by Annex A attached hereto.

 
Item 5. Interest in Securities of the Issuer.
 
6. The third paragraph of Item 5(a) of the
Statement is hereby amended and supplemented as follows:
 
“MCPS directly owns 24.57% of the total
capital stock of Lauro 57 (and thereby indirectly holds 4.05% of the Issuer). MCMS owns 10% of the total capital stock of MCPS
(and thereby indirectly holds 0.405% of the Issuer).”
  
7. The first paragraph of Item 5(b) of the
Statement is hereby amended and supplemented as follows:
 
“On August 5, 2016, the shareholders
of Lauro 57 entered into a Patto Parasociale Consolidato (i.e., a Shareholders Agreement) to amend and replace the
Lauro 57 Shareholders Agreement and implement and supersede the Memorandum of Understanding (the “Amended Lauro 57 Shareholders
Agreement”). The Effective Date of the Amended Lauro 57 Shareholders Agreement is September 28, 2016 (the “Effective
Date”). As of the Effective Date, each of Lauro 48 and MCPS have the right to appoint a director to Lauro 57’s
three member board of directors and each such director must approve any action of Lauro 57’s board of directors, including
any disposition of the Issuer’s Common Stock held by Lauro 57. As of the Effective Date, no shareholder of Lauro 57 has any
“drag along” rights under the Amended Lauro 57 Shareholders Agreement.”
  
Item 7.  Material to be Filed as Exhibits.
 


Exhibit No.
Description

7.10
Joint Filing Agreement, dated October 12, 2016, by and among Lauro 57, Lauro 48, Clessidra, MCPS and MCMS.

 

 8 
 

 
 
SIGNATURE
 
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Date: October 12, 2016

 




 
LAURO CINQUANTASETTE S.P.A.

 
 

 
By:
/s/ Enrico Ricotta

 
 
Name: Enrico Ricotta

 
 
Title:   Director

 
 
 

 
LAURO QUARANTOTTO S.P.A.

 
 

 
By:
/s/ Marco Carotenuto

 
 
Name: Marco Carotenuto

 
 
Title:   Chairman

 
 
 

 
CLESSIDRA S.G.R. S.P.A.

 
 

 
By:
/s/ Riccardo Bruno

 
 
Name: Riccardo Bruno

 
 
Title:   Director

 
 
 

 
MANDARIN CAPITAL PARTNERS 
SECONDARY S.C.A. SICAR

 
 

 
By:   Mandarin Capital Management Secondary S.A., its General Partner

 
 

 
By:
/s/ Massimo Longoni

 
 
Name: Massimo Longoni

 
 
Title:   Director

 
 
 

 
By:
/s/ Lorenzo Stanca

 
 
Name: Lorenzo Stanca

 
 
Title:   Director

  



 
MANDARIN CAPITAL MANAGEMENT 
SECONDARY S.A.

 
 
 

 
By:
/s/ Massimo Longoni

 
 
Name: Massimo Longoni

 
 
Title:   Director

 
 
 

 
By:
/s/ Lorenzo Stanca

 
 
Name: Lorenzo Stanca

 
 
Title:   Director

 



 9 
 

 
ANNEX A
 
Unless otherwise indicated below, the business
address of the directors and executive officers of Lauro 57, Lauro 48 and Clessidra is Via del Lauro, 7, 20121 Milano, Italy and
the business address of the directors and executive officers of MCPS and MCMS is 10, Rue Antoine Jans, L-1820 Luxembourg. Each
occupation set forth opposite such person’s name refers to employment with the Reporting Persons. To the Reporting Persons’
knowledge, none of the directors or executive officers of the Reporting Persons has, during the last five years, been convicted
in a criminal proceeding (excluding traffic violations or similar misdemeanors) or been a party to a civil proceeding of a judicial
or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment decree or final
order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or a
finding of any violation with respect to such laws.
 
Directors and Executive Officers of the
Reporting Persons.
 
Lauro 57:
 


Name
Occupation and 
Business Address
Number of Shares of Common Stock Owned
Citizenship

Piero Alonzo
Director & CEO
N/A
Italy

Marco Carotenuto
Director
N/A
Italy

Emiliano Nitti
Director
N/A
Italy

Enrico Ricotta
Director
N/A
Italy

Carlo Luigi Rossi
Director
N/A
Italy

Alberto Mangia
Director
N/A
Italy

Giovanni Campolo
Director
N/A
Italy

 
Lauro 48:
 


Name
Occupation and 
Business Address
Number of Shares of Common Stock Owned
Citizenship

Monica Maria Bianca Magrassi
Director & CEO
N/A
Italy

Marco Carotenuto
Director
N/A
Italy

Emiliano Nitti
Director
N/A
Italy

 
 


 10 
 


 
Clessidra:
 


Name
Occupation and 
Business Address
Number of Shares of Common Stock Owned
Citizenship

Carlo Pesenti
Chairman
N/A
Italy

Mario Fera
CEO
N/A
Italy

Riccardo Bruno
Director
N/A
Italy

Manuel Antonio Catalano
Director
N/A
Italy

Federico Ghizzoni
Director
N/A
Italy

Galeazzo Pecori Giraldi
Director
N/A
Italy

Alessandra Manuli
Director
N/A
Italy

 
MCPS:
 


Name
Occupation and 
Business Address
Number of Shares of Common Stock Owned
Citizenship

Mandarin Capital Management Secondary S.A.
Director
0.405%
Luxembourg

 
MCMS:
 


Name
Occupation and 
Business Address
Number of Shares of Common Stock Owned
Citizenship

Lorenzo Stanca
Director
N/A
Italy

Massimo Longoni
Director
N/A
Italy

Zheng Gao
Director
N/A
China

 

 11 

 
 









Elevate your investments
Try it for free
















LAURO CINQUANTASETTE S.P.A. Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      LAURO CINQUANTASETTE S.P.A.
                    

•   MILANO, L6
                      
How do I update this listing?




                                             Lauro Cinquantasette S.p.a. is based out of Milano.    WhaleWisdom has at least 3 13D/G filings in our database for Lauro Cinquantasette S.p.a..
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from LAURO CINQUANTASETTE S.P.A., enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




lauro cinquantasette s.p.a.


VIA DEL LAURO, 7

MILANO
L6
                                                        
                                                    20121


              Business Phone:
              39-02-8695221







Recent SEC Filings




SC 13D/A filed on 10/12/2016
SC 13D/A filed on 08/08/2016
SC 13D filed on 07/18/2016
3 filed on 07/18/2016











Current 13D/G Holdings


Stock
Sector
Shares Held
Market Value
Rank
Source
Source Date





Albany Molecular Research Inc (AMRI)


      HEALTH CARE
    

      7,051,295
    

      115,570,725.05
    

      1
    

      13D
    

      2016-09-28
    











Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free

















Stock Screener - Yahoo FinanceHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreYahooSearchSearch0U.S. Markets closedS&P 5002,477.13+7.22 (+0.29%)Dow 3021,613.43+100.26 (+0.47%)Insider TransactionsDefault CriteriaInsider & Restricted Shareholder Transactions1-1 of 1 resultsResults were generated a few mins ago. Pricing data is updated frequently. Currency in USDSymbolDateSharesProceedsTransaction DetailsAMRI2016-07-10N/AN/AStatement of OwnershipChina's army looks like it's getting ready for something big to go down in North KoreaBusiness InsiderDoes your car qualify for Uber?UberSponsoredBy a hair, Senate votes to debate GOP health care billAssociated PressYahoo Small BusinessData DisclaimerHelpSuggestionsPrivacyAbout Our AdsTerms (Updated)








[News] Albany Molecular Research Inc. (AMRI) St ... | Veooz 360
































































English







Top Stories




Videos




Local







USA







World News




News




Entertainment




Sports




Business




Technology




Lifestyle




Sign in  to follow topics.










 	    Select Feed
	









Albany Molecular Research Inc. (AMRI) Stake Held by Bessemer Trust Company of Delaware NA



Summary


Related


Buzz





	        more from Watch List News











































 






Albany Molecular Research Inc. (AMRI) Stake Held by Bessemer Trust Company of Delaware NA




        Watch List News
     	
·
12 months ago


Bessemer Trust Company of Delaware NA stated that they own 10.9% of Albany Molecular Research Inc. (NASDAQ:AMRI) in a Schedule 13D disclosure that was filed with the SEC on Wednesday, July 20th. On May 5, 2016, the Issuer and Lauro Cinquantasette S.p.A., a company organized under the laws of Italy (the "Seller"), entered into a Share Purchase Agreement (the "Share Purchase Agreement") pursuant to which, on July 11, 2016 (the "Closing"), the Issuer purchased 100% of the capital stock of Prime European Therapeuticals S.p.A.






Save



Share

























Read full story »
































